Original Research
Published on 18 Jul 2019
Different Levels of Incomplete Terminal Pathway Inhibition by Eculizumab and the Clinical Response of PNH Patients
in Molecular Innate Immunity
- 6,167 views
- 19 citations
Original Research
Published on 18 Jul 2019
in Molecular Innate Immunity
Original Research
Published on 16 May 2017
in Nutritional Immunology
Original Research
Published on 24 Dec 2021
in Molecular Innate Immunity
Perspective
Published on 11 Feb 2022
in Cancer Immunity and Immunotherapy
Review
Published on 24 Apr 2019
in Microbiological Chemistry and Geomicrobiology
Mini Review
Published on 14 Sep 2022
in Molecular Innate Immunity
Review
Published on 26 Mar 2025
in Neuro-Ophthalmology
Original Research
Published on 28 Oct 2020
in Molecular Innate Immunity
Original Research
Published on 29 Nov 2018
in Molecular Innate Immunity
Original Research
Published on 20 Aug 2014
in Synthetic Biology
Systematic Review
Published on 25 May 2023
in Primary Immunodeficiencies
Original Research
Published on 05 Sep 2022
in Molecular Innate Immunity
Original Research
Published on 29 Jun 2023
in Microbial Immunology
Review
Published on 07 Feb 2020
in Cardiovascular and Smooth Muscle Pharmacology
Original Research
Published on 30 May 2017
in Microbial Immunology
Original Research
Published on 08 Aug 2018
in Immunological Tolerance and Regulation